New pharmaceutical approaches to the treatment of cystic fibrosis. Gene therapy for cystic fibrosis is advancing rapidly but drug therapy is quickly catching up (pages 467-469)

Nature Medicine

Volumn 2, Issue 4, 1996, Pages 392-393

  Delaney, Stephen J ^a   Wainwright, Brandon J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC G 418; CHLORIDE CHANNEL; GENTAMICIN; GLYCEROL; ISOBUTYLMETHYLXANTHINE; PHOSPHODIESTERASE INHIBITOR; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; SODIUM CHANNEL; TOBRAMYCIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; URIDINE TRIPHOSPHATE;

CLINICAL TRIAL; CYSTIC FIBROSIS; GENE MUTATION; GENE THERAPY; HUMAN; NOTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SODIUM ABSORPTION; STOP CODON;

CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENE THERAPY; HUMANS;

EID: 0029898456     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0496-392     Document Type: Article

References (14)

1. Crystal, R.G. Transfer of genes to humans: Early lessons and obstacles to success. Science 270, 404-410 (1995).
2. Welsh, M.J. & Smith, A.E. Cystic fibrosis. Sci. Am. 273 (Dec.), 52-59 (1995).
3. Howard, M. et al. Aminoglycoside antibiotics restore CFTR function by suppressing premature stop mutations. Nature Med. 2, 467-469 (1996).
4. Welsh, M.J. & Smith, A.E. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73, 1251-1254 (1993).
5. - channel. Cell 76, 1091-1098 (1994).
6. Sato, S. et al. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J. Biol. Chem. 271, 635-638 (1996).
7. Becq, F. et al. Phosphatase inhibitors activate normal and defective CFTR chloride channels. Proc. Natl. Acad. Sci. USA 91, 9160-9164 (1994).
8. Stutts, M.J. et al. CFTR as a cAMP-dependent regulator of sodium channels. Science 269, 847-850 (1995).
9. Schwiebert, E.M. et al. CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP. Cell 81, 1063-1073 (1995).
10. Knowles, M.R. et al. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N. Engl. J. Med. 322, 1189-1194 (1990).
11. Noone, P.G. et al. Modulation of the ionic milieu of the airway in health and disease. Annu. Rev. Med. 45, 421-434 (1994).
12. Colledge, W.H. et al. Generation and characterization of a ΔF508 cystic fibrosis mouse model. Nature Genet. 10, 445-452 (1995).
13. Zeiher, B.G. et al. A mouse model for the ΔF508 allele of cystic fibrosis. J. Clin. Invest. 96, 2051-2064 (1995).
14. Delaney, S.J. et al. Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype-phenotype correlations. EMBO J. 15, 955-963 (1996).